A Real‐World Experience of Prognostic Factors of Survival Outcomes in a Taiwanese Population With Unresectable Hepatocellular Carcinoma Treated With First‐Line Lenvatinib
ABSTRACT Introduction Lenvatinib is approved as a first‐line treatment for unresectable hepatocellular carcinoma (HCC), but real‐world outcomes may vary due to patient heterogeneity. This study aimed to evaluate the real‐world efficacy of lenvatinib in Taiwanese patients and to identify prognostic f...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2026-05-01
|
| Series: | Cancer Medicine |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/cam4.71944 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|